Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Sean_McCarthy
|
| gptkbp:collaboratedWith |
gptkb:AbbVie
gptkb:Amgen gptkb:Astellas_Pharma gptkb:Bristol_Myers_Squibb |
| gptkbp:developedBy |
Probody therapeutics
|
| gptkbp:focusesOn |
oncology
immuno-oncology |
| gptkbp:foundedYear |
2008
|
| gptkbp:founder |
gptkb:Sean_McCarthy
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
CytomX Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
CX-072
CX-2009 CX-2029 |
| gptkbp:specializesIn |
antibody-drug conjugates
targeted cancer therapies |
| gptkbp:stockSymbol |
CTMX
|
| gptkbp:website |
https://www.cytomx.com/
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|